share_log
Moomoo 24/7 ·  Mar 28 07:24
Akebia Therapeutics Shares Are Trading Higher After the FDA Approved Vafseo Tablets for Treatment of Anemia Due to Chronic Kidney Disease in Adult Patients on Dialysis
Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment